谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Phase Ii Open Label Study of the Oral Vascular Endothelial Growth Factor-Receptor Inhibitor Ptk787/Zk222584 (vatalanib) in Adult Patients with Refractory or Relapsed Diffuse Large B-Cell Lymphoma

Danielle Brander,David Rizzieri,Jon Gockerman,Louis Diehl,Thomas Charles Shea,Carlos Decastro,Joseph O. Moore,Anne Beaven

LEUKEMIA & LYMPHOMA（2013）

引用 5|浏览8
暂无评分
关键词
PTK787/ZK222584,vatalanib,angiogenesis,diffuse large B-cell lymphoma
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要